Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection inSouthern Taiwan, 2000-2005: Upsurge in Hepatitis C virus infections among injection drug users

Journal of the Formosan Medical Association

Volumn 107, Issue 5, 2008, Pages 404-411

  Lee, Hsin Chun ^a,b   Ko, Nai Ying ^a   Lee, Nan Yao ^b   Chang, Chia Ming ^b   Ko, Wen Chien ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Human immunodeficiency virus; Sexually transmitted diseases; Transmission routes; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG USE; ENTAMOEBA HISTOLYTICA; FEMALE; FLUORESCENT TREPONEMA ANTIBODY TEST; HEALTH PROGRAM; HEMAGGLUTINATION TEST; HEPATITIS C; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; PREVENTION AND CONTROL; RETROSPECTIVE STUDY; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TAIWAN; TREND STUDY; VIRUS CARRIER; VIRUS HEPATITIS;

EID: 44949106445     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60106-0     Document Type: Article

References (35)

1. Twu SJ, Huang YF, Lai AC, et al. Update and projection on HIV/AIDS in Taiwan. AIDS Educ Prev 2004;16:53-63.
2. Chen YM, Lan YC, Lai SF, et al. HIV-1 CRF07_BC infections, injecting drug users, Taiwan. Emerg Infect Dis 2006;12: 703-5.
3. Lin HH, Shih YL, Liu YC, et al. An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan. J Acquir Immune Defic Syndr 2006;42:248-55.
4. Verucchi G, Calza L, Manfredi R, et al. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 2004;32:33-46.
5. Amin J, Kaye M, Skidmore S, et al. HIV and hepatitis C coinfection within the CAESAR study. HIV Med 2004; 5:174-9.
6. Lincoln D, Petoumenos K, Dore GJ. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003;4:241-9.
7. Agwale SM, Tanimoto L, Womack C, et al. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 2004;31 Suppl 1:S3-6.
8. Padmapriyadarsini C, Chandrabose J, Victor L, et al. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function. J Postgrad Med 2006;52:92-6.
9. Konopnicki D, Mocroft A, de WS, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005;19:593-601.
10. Joffe H, Bamberger E, Nurkin S, et al. Sexually transmitted diseases among patients with human immunodeficiency virus in northern Israel. Isr Med Assoc J 2006;8:333-6.
11. Chen SC, Wang ST, Chen KT, et al. Analysis of the influence of therapy and viral suppression on high-risk sexual behaviour and sexually transmitted infections among patients infected with human immunodeficiency virus in Taiwan. Clin Microbiol Infect 2006;12:660-5.
12. McGowan JP, Shah SS, Ganea CE, et al. Risk behavior for transmission of human immunodeficiency virus (HIV) among HIV-seropositive individuals in an urban setting. Clin Infect Dis 2004;38:122-7.
13. Erbelding EJ, Chung SE, Kamb ML, et al. New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior. J Acquir Immune Defic Syndr 2003;33:247-52.
14. Garten RJ, Zhang J, Lai S, et al. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 2005;41 Suppl 1:S18-24.
15. Bonacini M, Louie S, Bzowej N, et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004;18:2039-45.
16. De LA, Bugarini R, Lepri AC, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002;162:2125-32.
17. Chien YC, Jan CF, Kuo HS, et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28:126-35.
18. Lai MY. Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan. Intervirology 2006;49:91-5.
19. Center for Disease Control. HIV/AIDS. Available at http://www.cdc.gov.tw/file/39106_3526388889.xls [Date accessed: May 20, 2007] Taipei, Taiwan: Center for Disease Control, 2007. [In Chinese]
20. Hung CC, Chang SC. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 2004;54:849-53.
21. Hung CC, Hsiao CF, Chen MY, et al. Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006;59:222-8.
22. Fang CT, Hsu HM, Twu SJ, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 2004;190: 879-85.
23. Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet 2007;369: 623-5.
24. Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991; 13:830-3.
25. Chang CJ, Ko YC, Liu HW. Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan. J Formos Med Assoc 1998;97:826-9.
26. Chang CJ, Lin CH, Lee CT, et al. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol 1999;15:597-601.
27. Wu JS, Lu CF, Liu WT, et al. Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1991;24:55-60.
28. Wang JT, Wang TH, Lin JT, et al. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 1995;10: 454-8.
29. Yang CS, Chang HH, Chou CC, et al. Isolation effectively prevents the transmission of hepatitis C virus in the hemodialysis unit. J Formos Med Assoc 2003;102:79-85.
30. Chen CK, Su LW, Lin SK. Characteristics of hospitalized heroin smokers and heroin injectors in Taiwan. Changgeng Yi Xue Za Zhi 1999;22:197-203.
31. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000;18 Suppl 1:S61-4.
32. Wang SM, Liu CC, Huang YS, et al. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol 2001;64:104-8.
33. Hung CC, Deng HY, Hsiao WH, et al. Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch Intern Med 2005;165:409-15.
34. Wang SF, Liu SC, Lin SF, et al. Analysis and testing for AIDS in 92 homosexuals at a private party. Epidemiology Bulletin of Center for Diseases Control, Department of Health, Taiwan. 2004;20:105-20.
35. Ko NY, Lee HC, Chang JL, et al. Prevalence of human immunodeficiency virus and sexually transmitted infections and risky sexual behaviors among men visiting gay bathhouses in Taiwan. Sex Transm Dis 2006;33:467-73.